Viral Vectors
Risk-Based Optimization of Viral Vector Processes Adds Real Value
Elie Hanania, Ph.D.; Tatiana Mello, M.S.
Avid Bioservices
PAO-09-022-CL-05Oct 25, 2022
Antibiotic Resistance
Antibiotic Resistance: Advances in Understanding and Drug Development
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-07Oct 11, 2022
Column: New Drug Watch
Potential Applications for Antisense Oligonucleotide Therapies Continue to Expand
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-06Oct 11, 2022
Cell and Gene Therapy
State of the Cell and Gene Therapy Market
James Grote
Nice Insight
PAO-10-022-NI-01Oct 11, 2022
mRNA
Limitless Potential of mRNA Creates Tremendous Excitement Despite Uncertainties
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-022-NI-02Oct 11, 2022
Precision Medicine
Examining the Potential of Precision/Personalized Medicine
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-03Oct 11, 2022
Column: Supply Chain
Reimagining the Pharmaceutical Supply Chain
Danielle Alvarez
Pharma's Almanac
PAO-10-022-NI-04Oct 11, 2022
Big Data
Leveraging Big Data, Artificial Intelligence, and Machine Learning for Drug Discovery, Development, Manufacturing, and More
Cynthia A. Challener, Ph.D.; David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-022-NI-05Oct 11, 2022
Future of the Industry
What key indicators do you look at to predict the future of this industry?
Pharma's Almanac
PAO-10-022--RT-02Oct 11, 2022
Sustainability
What is your plan to build a more sustainable business practice in the coming years?
Pharma's Almanac
PAO-10-022--RT-01Oct 11, 2022
Transient Expression
Overcoming Limitations with Transient Protein Expression to Accelerate Development
Cenk Sumen, Ph.D.
MaxCyte
PAO-10-022-CL-02Oct 11, 2022
Clinical Workflow Integration
How All Clinical Trial Stakeholders Can Collaborate as One Study Team
OneStudyTeam
PAO-10-022-CL-01Oct 10, 2022
European DCTs
Exploring Challenges and Considerations for Operationalizing DCTs in the European Union
Kamilla Posselt
PPD, part of Thermo Fisher Scientific
PAO-09-022-CL-07Oct 06, 2022
Real-Time Monitoring
Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing
Stacy Shollenberger
MilliporeSigma
PAO-09-022-CL-08Sep 30, 2022
Digital Health Solutions
Beyond Drug Sales: Adding Value with Digital Health
Gérard Klop; Marcos Gallego Llorente, Ph.D.
PAO-08-022-CL-05Sep 28, 2022
Neurodegenerative Disease Clinical Trials
Preparing for Growth in Neurodegenerative Treatment Opportunities: How Clinical Teams can Best Position Study Design and Strategy to Reach Study Participants
John Hamlet; Christine Martino, MPM; Sabine Krofczik-Wilhelm, Ph.D.; Alberto Lledó, M.D., Ph.D.
PPD, part of Thermo Fisher Scientific
PAO-09-022-CL-09Sep 27, 2022
Clinical Trials Adherence
Evolving Solutions to Optimize Clinical Trial Decentralization
Tim Rich; John Musaus
PPD, part of Thermo Fisher Scientific
PAO-09-022-CL-06Sep 24, 2022
Speed to Clinic
Leveraging Experience to Reduce Timelines for IND-Enabling Activities
Muctarr Sesay, Ph.D.; Andrew Majdoch, M.Sc.
GBI
PAO-09-022-CL-04Sep 19, 2022
Biodefense
Supporting Biodefense Countermeasures with Strong Capabilities and Expertise
Brian O’Mara
Scorpius BioManufacturing
PAO-09-022-CL-03Sep 19, 2022
CDMO
Asymchem: Leading with Technology
Asymchem
PAO-09-022-CL-01Sep 13, 2022